Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Haemonetics Corporation

HAE•NYSE
Healthcare
Medical - Instruments & Supplies
$61.29
$0.10(0.16%)
U.S. Market opens in 15h 52m

Haemonetics Corporation (HAE) Stock Overview

Explore Haemonetics Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.9B
P/E Ratio16.42
EPS (TTM)$3.63
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$61.40
3 Months$73.31
1 Year Target$64.09

HAE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haemonetics Corporation (HAE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.97, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $64.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 16.42 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.15%
5-Day Change
4.38%
1-Month Change
-10.96%
3-Month Change
-22.22%
6-Month Change
8.71%
Year-to-Date (YTD) Change
-23.38%
1-Year Change
-7.04%
3-Year Change
-23.78%
5-Year Change
-53.53%
All-Time (Max) Change
932.08%

Contact Information

https://www.haemonetics.com
781 848 7100
125 Summer Street, Boston, MA, 02110

Company Facts

36,570 Employees
IPO DateMay 10, 1991
CountryUS
Actively Trading

Frequently Asked Questions